GlassScriptPhysician profile
Heather R Bartos
NPI 1982894903
$46,675.43
in general payments reported to CMS, 2019-2025
32 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $50.02 · 2021: $1,598 · 2022: $7,539 · 2023: $9,025 · 2024: $18K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33K · Food and Beverage: $2,316 · Travel and Lodging: $2,281 · Education: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $32,580.00 |
| Food and Beverage | $2,315.67 |
| Travel and Lodging | $2,281.38 |
| Education | $101.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $36,127.78 | 2023-2025 | Veozah |
| Intuitive Surgical, INC. | $5,566.46 | 2022-2023 | Da Vinci Surgical System |
| Organon LLC | $2,917.52 | 2021-2024 | Nexplanon |
| Abbvie INC. | $630.11 | 2019-2024 | Ubrelvy, Liletta, Qulipta |
| Novo Nordisk INC | $223.46 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Exeltis, USA INC. | $131.72 | 2022-2025 | Slynd |
| Minerva Surgical, INC | $85.19 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $83.15 | 2022 | |
| Lilly USA, LLC | $67.06 | 2019-2025 | Zepbound, Jardiance |
| Aspira Women'S Health INC | $65.48 | 2022 | |
| Hologic Sales and Service, LLC | $65.46 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Pfizer INC. | $65.41 | 2024 | |
| Myriad Women'S Health, INC. | $64.40 | 2023 | Myrisk |
| Allergan, INC. | $62.49 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $56.65 | 2023-2024 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $55.51 | 2022-2024 | Wavewriter Alpha Prime 16 |
| Sumitomo Pharma America, INC. | $51.16 | 2023-2024 | Myfembree |
| Dexcom, INC. | $41.71 | 2024-2025 | Dexcom G6 Transmitter |
| Monaghan Medical Corporation | $38.56 | 2023 | Aeroeclipse |
| Corcept Therapeutics | $30.95 | 2025 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.43 | 2019 | |
| Ascensia Diabetes Care US INC. | $28.32 | 2023 | |
| Merck Sharp & Dohme LLC | $24.84 | 2019-2021 | |
| Millicent US INC | $23.78 | 2019 | |
| Myovant Sciences INC. | $23.72 | 2022 | |
| Merz North America, INC. | $23.32 | 2025 | |
| Coopersurgical, INC. | $18.97 | 2023 | Mara Console |
| Alkermes, INC. | $18.39 | 2019 | |
| Exact Sciences Corporation | $17.56 | 2025 | The Cologuard Plus Collection Kit |
| Therapeuticsmd, INC. | $14.10 | 2019 | |
| Sage Therapeutics, LLC | $12.47 | 2022 | |
| Medicem INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Bartos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.